UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

___________________________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): ~~December~~February 2215, ~~2011~~2012

CHINA SKY ONE MEDICAL, INC. (Exact Name of ~~Registrant~~Registra5t as Specified in Charter)

Nevada	001-34080	87-0430322
(State or Other Jurisdiction	(Commission	(IRS Employer
of Incorporation)	File Number)	Identification No.)

No. 2158, North Xiang An Road, Song Bei District,

Harbin, People’s Republic of China 150028

(Address of Principal Executive Offices)

Registrant's telephone number, including area code:

86-451-87032617 (China)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 58.~~02.~~01 ~~Departure~~- ofOther ~~Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers~~Events

~~On December 16, 2011, Mr. Pan Hong-yu submitted an application of resignation to~~ China Sky One Medical, Inc. (the “Company”) regrets ~~seeking approval~~ to ~~resign~~report ~~from~~that ~~his~~its ~~positions~~Chairman, asPresident ~~Chief Financial Officer~~ and ~~Treasurer~~Chief ofExecutive ~~the Company prior to December 31~~Officer, ~~2011. The~~Liu ~~Company’s board of directors accepted Mr. Pan’s application for resignation on December 22~~Yang-qing, ~~2011~~is ~~and~~being ~~his~~treated ~~resignation became effective on that date. Mr. Pan’s application~~ for ~~resignation was for personal reasons and was not as~~ a ~~result~~life-threatening illness. ofFollowing ~~any~~surgery, ~~disagreement~~he ~~with~~is ~~the~~expected ~~Company on any matter relating~~ to ~~its~~undergo ~~operations,~~long-term ~~policies~~chemotherapy orand ~~practices. Mr.~~traditional ~~Pan~~Chinese ~~had~~medicine ~~been~~treatments ~~the Company’s Chief Financial Officer~~ and ~~Treasurer~~his availability ~~since~~to ~~November~~devote ~~19,~~time ~~2010. As~~to ~~a result of~~ the Company~~'s acceptance of Mr. Pan~~’s ~~application~~business ofwill ~~resignation,~~be hesubstantially ~~has relinquished his titles of “principal financial officer” and “principal accounting officer” for SEC reporting purposes~~reduced.

AIn ~~copy~~addition, 26 middle-management level employees have recently resigned, of which 9 were in the ~~press~~accounting ~~release~~department, ~~further~~2 ~~discussing~~were ~~this~~in ~~matter~~the isinternal ~~furnished~~controls asdepartment, ~~Exhibit~~2 were ~~99.1~~in the IT department, 11 were in the sales department, and 2 were in the production center. Although the Company is seeking ~~incorporated~~to ~~herein~~recruit bypersonnel, ~~reference~~it may not be able to hire qualified personnel in a timely manner or at all.

~~Item 9~~Mr.~~01.~~ ~~Financial~~Liu’s ~~Statements~~health concerns and ~~Exhibits~~absence and the loss of such management employees are likely to materially adversely affect many aspects of the Company’s business, including its ability to maintain customer relationships, meet production schedules, as well as its internal controls.

~~(d) Exhibits~~SIGNATURE

~~The~~Pursuant ~~exhibit~~to ~~listed~~the inrequirements of the ~~following~~Securities Exchange ~~Exhibit~~Act ~~Index~~of is1934, ~~filed~~the asRegistrant ~~part~~has ofduly caused this ~~Form~~report ~~8-K~~to be signed on its behalf by the undersigned hereunto duly authorized.

Exhibit Number		Exhibit Description
	CHINA SKY ONE MEDICAL, INC.
99.1		Press Release, dated December 28, 2011
	(Registrant)
Date: February 15, 2012	By:	/s/ Liu Yan-qing
		Liu Yan-qing
		Chairman, Chief Executive Officer and President

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	CHINA SKY ONE MEDICAL, INC.
		(Registrant)
Date: December 28, 2011	By:	/s/ Liu Yan-qing
		Liu Yan-qing
		Chairman, Chief Executive Officer and President

EXHIBIT INDEX

Exhibit Number		Exhibit Description
99.1		Press Release, dated December 28, 2011

Filing Compare · CHINA SKY ONE MEDICAL, INC.